secwatch.observer — SEC 8-K summary
======================================

Issuer:     Personalis, Inc. (PSNL)
CIK:        0001527753
Form:       8-K
Filed at:   2024-02-28T23:59:59+00:00
Accession:  0000950170-24-022032
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Personalis Q4 revenue $19.7M (+18% YoY); FY2024 revenue guidance $73-75M
------------------------------------------------------------------------

- Q4 2023 revenue $19.7M (+18% YoY); FY2023 revenue $73.5M (+13% YoY).
- Q4 net loss $26.6M ($0.54 EPS); FY net loss $108.3M ($2.25 EPS).
- FY2024 guidance: revenue $73-75M, net loss ~$80M (down from $108.3M), cash usage ~$62M.
- Obtained final Medicare coverage for NeXT Dx tumor profiling test; partnerships with Tempus, Myriad, ClearNote, and Natera extension.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527753/000095017024022032/0000950170-24-022032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527753/000095017024022032/psnl-20240228.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-022032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer